1. The antileukemic activity of Δ12-PGJ3
by Paul A. Ney
Blood
Volume 118(26):
December 22, 2011
©2011 by American Society of Hematology

2. Antileukemic activity of eicosapentaenoic acid (EPA)–derived cyclopentenone prostaglandins.
Antileukemic activity of eicosapentaenoic acid (EPA)–derived cyclopentenone prostaglandins. Left panel shows a liquid chromatography-UV trace of EPA-derived metabolites endogenously produced by macrophages. Right panel demonstrates the selective antileukemic effect of Δ12-PGJ3 on BCR-ABL–transformed leukemic stem cells.
Paul A. Ney Blood 2011;118:
©2011 by American Society of Hematology